Abstract: Pharmaceutical tablets comprising a first layer formulated for immediate release of telmisartan from a dissolving matrix and a second layer formulated for immediate release of hydrochlorothiazide from a dissolving matrix, methods for producing tablets and methods of use for treating hypertension.
Type:
Application
Filed:
October 30, 2008
Publication date:
September 30, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Inventors:
Uma Devi Palaparthi, Ashutosh Rout, Maheswara Reddy Arumalla
Abstract: Processes for preparing desvenlafaxine and stable amorphous O-desmethylvenlafaxine succinate solid dispersions with one or more pharmaceutically acceptable carriers.
Type:
Application
Filed:
July 10, 2008
Publication date:
August 19, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: The present invention provides crystalline polymorphs of docetaxel and processes for preparing them, a method for preparing amorphous docetaxel, and a process for preparing docetaxel.
Type:
Application
Filed:
March 20, 2007
Publication date:
June 24, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: Novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided. Additionally, methods of forming novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided.
Type:
Application
Filed:
September 3, 2009
Publication date:
June 10, 2010
Applicant:
Dr. Reddy's Laboratories Ltd.
Inventors:
Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti
Abstract: Novel heterocyclic compounds, sstereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided. Additionally, methods of forming novel heterocyclic compounds, stereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided.
Type:
Application
Filed:
September 3, 2009
Publication date:
June 10, 2010
Applicant:
Dr. Reddy's Laboratories Ltd.
Inventors:
Christopher W. Alexander, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti
Abstract: Compositions and/or formulations comprising solifenacin or a salt thereof and processes for preparing the same. Certain compositions and formulations contain a stable amorphous form of solifenacin succinate.
Type:
Application
Filed:
April 11, 2008
Publication date:
June 3, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: The present invention provides, among other things, new bicyclic heterocyclic compounds, compositions comprising these heterocyclic compounds, methods of making the heterocyclic compounds, and methods of using these heterocyclic compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
Type:
Grant
Filed:
December 20, 2005
Date of Patent:
April 20, 2010
Assignee:
Dr. Reddy's Laboratories Ltd.
Inventors:
Anima Baruah, Ish Khanna, Sivaram Pillarisetti
Abstract: There is provided a solid dispersion of imatinib mesylate that includes imatinib mesylate and a pharmaceutically acceptable carrier, wherein said carrier is a cellulose derivative. Also provided is a process for making a solid dispersion and a process for making imatinib.
Type:
Application
Filed:
March 12, 2008
Publication date:
April 8, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: There is provided a compound, which is dehydroabietylamine salt of rosuvastatin. Also provided are processes for making rosuvastatin calcium that include formation of dehydroabietylamine salt of rosuvastatin.
Type:
Application
Filed:
November 29, 2007
Publication date:
March 18, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Inventors:
Satyanarayana Bollikonda, Sridhar Chaganti, Ranga Reddy Tamma, Loka Maheshwari Pochaiah h Dommati
Abstract: Duplex coating schemes and associated methods of formation, including a siloxane-based soft coating and a plasma-based SiOxCy hard coating used in combination to improve the durability of polymeric substrates.
Type:
Application
Filed:
April 4, 2008
Publication date:
March 11, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: A 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diasterisomer is described which is a better inhibitor of topoisomerase I than either the diastereoisomeric mixture 5(RS)-(2?-hydroxyethoxy)-20(S)-camptothecin, or the 5(R)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer. Pharmaceutical compositions of the 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer are also described as are methods of using the compound for the inhibition of topoisomerase I and for the treatment of cancer.
Abstract: The present invention relates to pharmaceutical formulations of atorvastatin or its pharmaceutically acceptable salts, solvates, hydrates, enantiomers, polymorphs or their mixtures; and processes for preparing the same, and their methods of use, treatment and administration. Further, the present invention relates to pharmaceutical compositions comprising an acid-solubility-enhanced form of atorvastatin or its salts.
Type:
Application
Filed:
September 27, 2007
Publication date:
February 4, 2010
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: The present invention relates to solifenacin in solid form and a process for its preparation and to a process for the preparation of (1S)-1-Phenyl-1,2,3,4-tetrahydro-isoquinoline, a key intermediate in the synthesis of solifenacin and its salts.
Type:
Application
Filed:
July 18, 2007
Publication date:
December 31, 2009
Applicants:
Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.
Abstract: Pharmaceutical compositions comprising a plurality of formulated particles containing at least one active ingredient and at least one pharmaceutically acceptable excipient, granulated with a granulating composition containing at least one pharmaceutical excipient.
Type:
Application
Filed:
July 19, 2007
Publication date:
October 8, 2009
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Abstract: Single phase pharmaceutical compositions for topical application, in addition to kits and methods of use and administration are provided. The compositions comprise a biologically active agent; a delivery vehicle comprising at least a non-polymeric crystallization inhibitor and a film-former; and a volatile solvent; wherein the biologically active agent is present in the composition in a subsaturated state, the biologically active agent is present in the delivery vehicle in a supersaturated state, and the crystallization inhibitor is capable of delaying crystallization of the biologically active agent in the delivery vehicle. Biologically active agents include terbinafine and acyclovir. Treatments for onychomycosis and Varicella zoster infection, HSV-1 infection or HSV-2 infection are provided.
Type:
Application
Filed:
June 14, 2007
Publication date:
October 1, 2009
Applicants:
DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
Inventors:
Ake Lindahl, Birgitta Svensson, Anna Holmberg, Johan Engblom
Abstract: In accordance with one aspect, the present invention provides a compound of general formula (I), its stereoisomers thereof and/or its pharmaceutically acceptable salts thereof, which have antibacterial activity; with methods of treating infectious diseases in warm blooded animals employing these new compounds. wherein R1 is selected from optionally substituted alkyl.
Type:
Application
Filed:
September 8, 2008
Publication date:
April 30, 2009
Applicants:
Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.